Acta Pharmaceutica Sinica B
|
2026, 16(2): 1170-1172
• Corrections •
Author correction to “A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers” [Acta Pharmaceutica Sinica B 15 (2025) 3767–3787]
Full
Jialing Cheng1,2, Zhiyang Chen1,2, Demin Lin1,2, Yanfang Yang1,2, Yanjing Bai3, Lingshuang Wang3, Jie Li3, Yuchen Wang1, Hongliang Wang1,2, Youbai Chen4, Jun Ye1,2, Yuling Liu1,2
Affiliations
1 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;
2 Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China;
3 Shenzhen Xiuli Medicine Technology Co., Ltd., Xinlan Community, Shenzhen 518110, China;
4 Department of Plastic and Reconstructive Surgery, Chinese PLA General Hospital, Beijing 100853, China
doi: 10.1016/j.apsb.2025.12.034
Outline
Jialing Cheng, Zhiyang Chen, Demin Lin, Yanfang Yang, Yanjing Bai, Lingshuang Wang, Jie Li, Yuchen Wang, Hongliang Wang, Youbai Chen, Jun Ye, Yuling Liu.
Author correction to “A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers” [Acta Pharmaceutica Sinica B 15 (2025) 3767–3787][J].
Acta Pharmaceutica Sinica B,
2026
, 16
(2)
: 1170
-1172
.
DOI: 10.1016/j.apsb.2025.12.034
Year 2026 volume 16 Issue 2
PDF
7
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.12.034